[13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

C52H46N4OPt — CID 171724159

IUPAC[13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3ccccc3c3ccc(Oc4cccc(-n5cc6c7ccc(n6c5=[Pt])CCc5ccc(cc5)CC7)c4)cc32)nc(C)c1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C52H46N4O.Pt/c1-34-29-50(53-35(2)51(34)39-20-23-40(24-21-39)52(3,4)5)56-47-12-7-6-11-45(47)46-28-27-44(31-48(46)56)57-43-10-8-9-42(30-43)54-32-49-38-19-17-36-13-15-37(16-14-36)18-25-41(26-22-38)55(49)33-54;/h6-16,20-24,26-32H,17-19,25H2,1-5H3;
InChIKeyUVYJRODJEZOKDS-UHFFFAOYSA-N
MW938.04 g/mol
LogP12.56
Rot. Bonds5

About [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

[13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (PubChem CID 171724159) has the molecular formula C52H46N4OPt and a molecular weight of 938.04 g/mol. Its IUPAC name is [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.

Molecular Properties

Compound Name[13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
PubChem CID171724159
Molecular FormulaC52H46N4OPt
Molecular Weight938.04 g/mol
Exact Mass937.33
IUPAC Name[13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3ccccc3c3ccc(Oc4cccc(-n5cc6c7ccc(n6c5=[Pt])CCc5ccc(cc5)CC7)c4)cc32)nc(C)c1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C52H46N4O.Pt/c1-34-29-50(53-35(2)51(34)39-20-23-40(24-21-39)52(3,4)5)56-47-12-7-6-11-45(47)46-28-27-44(31-48(46)56)57-43-10-8-9-42(30-43)54-32-49-38-19-17-36-13-15-37(16-14-36)18-25-41(26-22-38)55(49)33-54;/h6-16,20-24,26-32H,17-19,25H2,1-5H3;
InChIKeyUVYJRODJEZOKDS-UHFFFAOYSA-N
XLogP12.56
TPSA36.39 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500938.04
LogP ≤ 512.56
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The IUPAC name of [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (CID 171724159) is [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.
What is the SMILES notation for [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The canonical SMILES for [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is Cc1cc(-n2c3ccccc3c3ccc(Oc4cccc(-n5cc6c7ccc(n6c5=[Pt])CCc5ccc(cc5)CC7)c4)cc32)nc(C)c1-c1ccc(C(C)(C)C)cc1.
What is the InChIKey of [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The InChIKey is UVYJRODJEZOKDS-UHFFFAOYSA-N. The full InChI is InChI=1S/C52H46N4O.Pt/c1-34-29-50(53-35(2)51(34)39-20-23-40(24-21-39)52(3,4)5)56-47-12-7-6-11-45(47)46-28-27-44(31-48(46)56)57-43-10-8-9-42(30-43)54-32-49-38-19-17-36-13-15-37(16-14-36)18-25-41(26-22-38)55(49)33-54;/h6-16,20-24,26-32H,17-19,25H2,1-5H3;.
What are the key properties of [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
[13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum has a molecular weight of 938.04 g/mol, XLogP of 12.56, 5 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [13-[3-[9-[5-(4-tert-butylphenyl)-4,6-dimethyl-2-pyridinyl]carbazol-2-yl]oxyphenyl]-11,13-diazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is sourced from PubChem (CID 171724159), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).